Much of the current excitement comes from retatrutides triple-agonist design and the Phase 2 obesity data, which created a strong next-generation narrative
Week 1 to 2: Most patients notice the sleep change first
Adapting in this environment is less about chasing trends and more about making your strengths easier to see and easier to access
Unlike Ozempic and Wegovy, theres no difference between Mourjano and Zepbound except for their names
Treatment of MDS-related TOD/complications in patient with T2D MDS-related chronic kidney disease We believe that, unlike classical T1D, T2D is a component of MDS and chronic kidney disease in T2D patients is supposed to be TOD/complications of MDS, since any component of MDS can cause the initiation and progression of CKD
Although these findings suggest potential benefits of GABA-related interventionsgiven carnosines proposed modulation of GABAergic activity and zinc/copper homeostasisthe mechanism remains unclear, and replication in larger, independent samples is needed (183)